Atlas Trials

Survival Data and Characteristics of Finisterian Patients Treated With PARP Inhibitors for Ovarian Cancer Between 2014 and 2019.

Clinical trial NCT04573933 · COMPLETED

Trial details

NCT number
NCT04573933
Sponsor
University Hospital, Brest
Status
COMPLETED
Study type
OBSERVATIONAL
Ovarian Neoplasm
Start date
2020-06-29
Primary completion
2020-07-29
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.